Dutch (AEX) Biotech Industry Analysis
UpdatedMay 22, 2024
DataAggregated Company Financials
Companies3
- 7D-1.0%
- 3M-29.2%
- 1Y-41.0%
- YTD-31.8%
Over the last 7 days, the Biotech industry has risen 1.3%, driven by gains from Galapagos of 3.2%. In the past year, the industry is down 37%. In the next few years, earnings are forecast to decline by 20% annually.
Industry Valuation and Performance
Has the Dutch Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 22 May 2024 | €2.3b | €481.6m | €20.8m | 56.7x | 110.2x | 4.8x |
| Fri, 19 Apr 2024 | €2.4b | €470.2m | -€40,186,846.00 | n/a | -59.7x | 5.1x |
| Sun, 17 Mar 2024 | €2.8b | €465.0m | -€39,571,301.50 | n/a | -70.2x | 6x |
| Tue, 13 Feb 2024 | €3.4b | €747.0m | -€199,829,451.00 | n/a | -17x | 4.6x |
| Thu, 11 Jan 2024 | €3.4b | €743.4m | -€199,472,160.00 | n/a | -17.2x | 4.6x |
| Sat, 09 Dec 2023 | €3.3b | €747.4m | -€199,875,767.00 | n/a | -16.6x | 4.4x |
| Mon, 06 Nov 2023 | €3.3b | €747.9m | -€199,926,493.00 | n/a | -16.4x | 4.4x |
| Wed, 04 Oct 2023 | €3.2b | €756.8m | -€199,288,563.00 | n/a | -16.3x | 4.3x |
| Fri, 01 Sep 2023 | €3.4b | €750.5m | -€200,646,605.00 | n/a | -16.9x | 4.5x |
| Sun, 30 Jul 2023 | €3.5b | €730.6m | -€211,439,665.00 | n/a | -16.7x | 4.8x |
| Tue, 27 Jun 2023 | €3.4b | €732.6m | -€211,459,415.00 | n/a | -16.2x | 4.7x |
| Thu, 25 May 2023 | €3.8b | €735.2m | -€211,484,752.00 | n/a | -18x | 5.2x |
| Sat, 22 Apr 2023 | €3.2b | €692.7m | -€233,685,884.00 | 51.4x | -13.9x | 4.7x |
| Mon, 20 Mar 2023 | €3.4b | €708.9m | -€218,735,890.00 | 46.9x | -15.3x | 4.7x |
| Wed, 15 Feb 2023 | €3.6b | €778.0m | €20.3m | 233.3x | 176x | 4.6x |
| Fri, 13 Jan 2023 | €3.9b | €776.3m | €20.1m | 269.7x | 196.4x | 5.1x |
| Sun, 11 Dec 2022 | €3.3b | €781.3m | €20.8m | 223.2x | 160.3x | 4.3x |
| Tue, 08 Nov 2022 | €3.6b | €791.8m | €22.4m | 255.9x | 162.7x | 4.6x |
| Thu, 06 Oct 2022 | €3.8b | €721.2m | -€73,022,888.00 | 31.5x | -52.2x | 5.3x |
| Sat, 03 Sep 2022 | €4.3b | €717.7m | -€72,475,710.00 | 39.5x | -59.5x | 6x |
| Mon, 01 Aug 2022 | €3.9b | €716.0m | -€127,837,306.00 | 46.4x | -30.7x | 5.5x |
| Wed, 29 Jun 2022 | €4.2b | €709.9m | -€128,168,607.00 | 48.3x | -32.6x | 5.9x |
| Fri, 27 May 2022 | €4.0b | €707.2m | -€128,317,309.00 | 48.4x | -31.5x | 5.7x |
| Sun, 24 Apr 2022 | €4.6b | €680.1m | -€122,147,511.00 | 35.7x | -37.5x | 6.7x |
| Tue, 22 Mar 2022 | €4.4b | €663.3m | -€123,499,000.00 | 35.2x | -35.4x | 6.6x |
| Thu, 17 Feb 2022 | €4.7b | €709.9m | -€193,509,000.00 | 29x | -24.1x | 6.6x |
| Sat, 15 Jan 2022 | €4.0b | €709.9m | -€193,509,000.00 | 28.3x | -20.7x | 5.7x |
| Mon, 13 Dec 2021 | €3.6b | €709.9m | -€193,509,000.00 | 24.7x | -18.9x | 5.1x |
| Wed, 10 Nov 2021 | €4.1b | €709.9m | -€193,500,000.00 | 26.7x | -21.4x | 5.8x |
| Fri, 08 Oct 2021 | €3.7b | €764.7m | -€212,734,000.00 | 19x | -17.6x | 4.9x |
| Sun, 05 Sep 2021 | €4.3b | €764.7m | -€208,635,000.00 | 21.6x | -20.8x | 5.7x |
| Tue, 03 Aug 2021 | €4.4b | €764.7m | -€208,635,000.00 | 23.2x | -21x | 5.7x |
Price to Earnings Ratio
-19.2x
Current Industry PE
- There are only 3 companies in the Dutch Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- Total earnings for the Biotechs industry have gone up over the last three years and the industry is now profitable.
- Revenues have declined 13% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, profits have been increasing.
Industry Trends
Which industries have driven the changes within the Dutch Healthcare industry?
| NL Market | 0.88% | |
| Healthcare | 0.25% | |
| Biotech | -0.97% | |
| Biotech | -0.97% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| VVY Vivoryon Therapeutics | €0.80 | 4.8% +€964.5k | -94.5% | PB0.8x |